150 related articles for article (PubMed ID: 33034556)
1. Preventing Breast, Cervical, and Colorectal Cancer Deaths: Assessing the Impact of Increased Screening.
Sharma KP; Grosse SD; Maciosek MV; Joseph D; Roy K; Richardson LC; Jaffe H
Prev Chronic Dis; 2020 Oct; 17():E123. PubMed ID: 33034556
[TBL] [Abstract][Full Text] [Related]
2. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ
JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
5. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
[No Abstract] [Full Text] [Related]
6. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
7. Cancer screening test use - United States, 2013.
Sabatino SA; White MC; Thompson TD; Klabunde CN;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):464-8. PubMed ID: 25950253
[TBL] [Abstract][Full Text] [Related]
8. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
[TBL] [Abstract][Full Text] [Related]
9. Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.
Mohan G; Chattopadhyay SK; Ekwueme DU; Sabatino SA; Okasako-Schmucker DL; Peng Y; Mercer SL; Thota AB;
Am J Prev Med; 2019 Oct; 57(4):557-567. PubMed ID: 31477431
[TBL] [Abstract][Full Text] [Related]
10. [The diffusion of screening programmes in Italy, year 2010].
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
[TBL] [Abstract][Full Text] [Related]
11. Mediators of county-level racial and economic privilege in cancer screening.
Munir MM; Woldesenbet S; Alaimo L; Moazzam Z; Lima HA; Endo Y; Beane J; Kim A; Dillhoff M; Cloyd J; Ejaz A; Pawlik TM
J Surg Oncol; 2023 Jun; 127(7):1212-1222. PubMed ID: 36932957
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
13. Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults.
Moss JL; Roy S; Shen C; Cooper JD; Lennon RP; Lengerich EJ; Adelman A; Curry W; Ruffin MT
JAMA Netw Open; 2020 Jul; 3(7):e2011645. PubMed ID: 32716514
[TBL] [Abstract][Full Text] [Related]
14. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.
Lee SJ; Boscardin WJ; Stijacic-Cenzer I; Conell-Price J; O'Brien S; Walter LC
BMJ; 2013 Jan; 346():e8441. PubMed ID: 23299842
[TBL] [Abstract][Full Text] [Related]
15. Associations of multimorbidity with breast, cervical, and colorectal cancer screening delivery: a cross-sectional study of a nationally representative Japanese sample.
Yamashita H; Takahashi Y; Ishizaki T; Imura H; Nakayama T
Cancer Epidemiol; 2020 Dec; 69():101798. PubMed ID: 32980753
[TBL] [Abstract][Full Text] [Related]
16. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
Charkhchi P; Schabath MB; Carlos RC
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
[TBL] [Abstract][Full Text] [Related]
17. Delivery of preventive services.
Hahn DL
J Am Board Fam Pract; 2000; 13(3):228-30. PubMed ID: 10826879
[No Abstract] [Full Text] [Related]
18. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
19. Cancer worries and uptake of breast, cervical, and colorectal cancer screening: A population-based survey in England.
Quaife SL; Waller J; von Wagner C; Vrinten C
J Med Screen; 2019 Mar; 26(1):3-10. PubMed ID: 30249158
[TBL] [Abstract][Full Text] [Related]
20. Methods to increase participation in organised screening programs: a systematic review.
Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
